There is growing awareness that complex interactions among multiple genes and environmental factors play an important role in controlling obesity traits. The BSB mouse, which is produced by the backcross of (lean C57BL/6J ϫ lean Mus spretus) ϫ C57BL/6J, provides an excellent model of epistatic obesity. To evaluate potential epistatic interactions among six chromosomal regions previously determined to influence obesity phenotypes, we performed novel Bayesian analyses on the basis of both epistatic and nonepistatic models for four obesity traits: percentage of body fat, adiposity index, total fat mass, and body weight, and also for plasma total cholesterol. The epistatic analysis detected at least one more QTL than the nonepistatic analysis did for all obesity traits. These obesity traits were variously influenced by QTL on chromosomes 2, 7, 12, 15, and 16. Interaction between genes on chromosomes 2 and 12 was present for all obesity traits, accounting for 3-4.8% of the phenotypic variation. Chromosome 12 was found to have weak main effects on all obesity traits. Several different epistatic interactions were also detected for percentage of body fat, adiposity index, and total fat mass. Chromosomes 6 and 12 have not only main effects but also strong epistatic effects on plasma total cholesterol. Our results emphasize the importance of modeling epistasis for discovery of obesity genes.
T HE underlying biological causes of obesity are comobesity has been derived from statistical analyses (Segal and Allison 2002) , but is also apparent from the almost plex, including genes with large effects that are independent of environment and epistasis, genes whose universal observation that obesity phenotypes of knockout and spontaneous mutant mice are dependent on alleles interact with the environment to produce obesity in some individuals and not others, and genes that interthe background mouse strain on which the mutations are placed (Hummel et al. 1972 ; Coleman and Hummel act with each other . Understanding the overall biological etiology of obesity will require 1973; Harris et al. 2001; Hofmann et al. 2001) . That is, different alleles of genes other than the knockout or identification of genes responsible for each of these different mechanisms. Discrete combinations of alleles mutant gene present in different mouse strains interact with (are epistatic with) the knockout or mutation. of genes, or gene products, may interact with each other in markedly different ways to influence complex dis-
In the BSB mouse model, mice are produced by a backcross of the lean female M. musculus domesticus (ineases (Cordell 2002; Moore 2003) . These epistatic interactions clearly influence obesity (Brockmann et al. bred C57BL/6J) with lean male M. spretus (either outbred SPRET/Pt or inbred SPRET/Ei). The lean F 1 fe-2000; Dong et al. 2003) . The observation that obesity is influenced by epistasis has implications for gene discovmales are then backcrossed to C57BL/6J to produce the BSB model. Each mouse is genetically unique and ery and becomes particularly important if epistasis underlies a significant fraction of human obesity as appears body fat can range from 1 to Ͼ50%. Since both parental strains and F 1 's are lean on low-fat chow diets, then to be true for mice (Brockmann et al. 2000; Cheverud et al. 2001; Corva et al. 2001) . The practical implication obesity in BSB mice may be due to interactions between alleles from the two strains . Two of epistasis for experimental work is that some quantitative trait loci (QTL) that have no independent effects previous studies, using either outbred SPRET/Pt or inbred SPRET/Ei, reported obesity and/or cholesterol may be identified, but that these loci may significantly influence the trait if combined with a specific allele quantitative trait loci (QTL) in BSB mice on chromosomes 6, 7, and 15 (Warden et al. , 1995 . A QTL of another gene. Evidence that epistasis is common in on chromosome 12 was observed in one cross, but not in another (Warden et al. 1995) . In addition, a chromosome 16 QTL was observed in the wild-type cross (C. H. QTL was found in the crosses examined in the present study . ) on chromosome 9, and inbred M. spretus (SPRET/Ei) were obtained from the Jackson Laboratory (Bar Harbor, ME).
Chromosome 7 BSB mice are the result of crossing male SPRET/Ei mice with D7Mit185 87.7 50.0 0.0 female C57BL/6J mice and then backcrossing the female F 1 D7Mit8 Not mapped 60.0 10.3 progeny to male C57BL/6J mice Physical location is the position in megabases of the marker in the Ensembl public mouse genome assembly. Linkage is the Phenotypic measures: At ‫5ف‬ months of age, mice were fasted overnight and bled from the retro-orbital plexus under location in Kosambi centimorgans of the microsatellite marker in the Mouse Genome Database at The Jackson Laboratory isoflurane anesthesia ‫3ف‬ hr after the beginning of the light cycle. Blood was collected in plasma separator tubes, placed (http:/ /www.informatics.jax.org/). BSB (cM) is the measured marker-to-marker distance in the BSB mice used for analysis on ice, and centrifuged to prepare plasma. Total cholesterol was measured as previously described (Castellani et al. 1997;  of the present data. 
(2) (Kimble Glass, Vineland, NJ) and total fat mass was determined gravimetrically (Bell and Stern 1977) . Percentage of body fat
In Equation 2, the residual error e i includes epistatic efwas calculated as total fat mass Ϭ carcass weight ϫ 100.
fects and environmental error. Other terms are defined as Genotyping: Genomic DNA was extracted from mouse kidabove. Under the nonepistatic model, the l putative QTL are ney (QIAamp blood and tissue kit; QIAGEN, Valencia, CA).
chosen only on the basis of their significant main effects. Using Simple sequence length polymorphism (SSLP) markers, polythe epistatic model, however, one is able to find QTL with morphic between C57BL/6J and SPRET/Ei alleles, on chroeither significant main effects or epistatic effects. mosomes 2, 6, 7, 12, 15, and 16 (Table 1) , were genotyped
The multiple-QTL models were analyzed using Bayesian by amplification (Invitrogen, Carlsbad, CA). PCR used 30 cymethods. In a Bayesian framework, the statistical inference is cles of 94Њ for 30 sec, 55Њ for 30 sec, and 68Њ for 30 sec. PCR based on the joint posterior distribution of all unknowns in products were separated by 2% agarose gel electrophoresis the model given the observed data. The observed data include and visualized by ethidium bromide staining and UV illuminathe phenotypic values and the marker genotypes. The unknowns tion. We genotyped chromosomes where there was previous include the number of QTL, genomic locations of QTL, effect evidence for QTL in BSB mice.
indicators, main effects, epistatic effects, overall mean, residStatistical analyses: Five phenotypes, percentage of body fat, ual variance, genotypes of missing markers, and genotypic adiposity index, total fat mass, body weight, and plasma total indicators of putative QTL. Calculation of the joint posterior cholesterol, were analyzed in this study. Two multiple-QTL distributions is analytically intractable, and thus a Markov models, an epistatic model and a nonepistatic model, were chain Monte Carlo (MCMC) approach is utilized to obtain used to analyze the data. The multiple-QTL models fit all posterior samples from the joint posterior distribution. We putative QTL simultaneously and jointly estimate the number, used the Bayesian method and MCMC algorithm developed genomic positions, and genetic effects of QTL. We assume by Yi et al. (2003) to generate posterior samples from the joint that an obesity trait is affected by l QTL. Under the epistatic posterior distribution and then estimate the number, locamodel, observed phenotypic value of the ith mouse, y i , can be tions, main effects, and epistatic effects of QTL simultaneously described by the following linear model, using the posterior samples. Briefly, the MCMC algorithm consisted of the following steps: (a) update the model parame-
. . , n, ters (main effects, epistatic effects, overall mean, and residual variance); (b) update the genotypic indicators of QTL and (1) the genotypes of missing markers; (c) update the locations of where n is the number of animals in the mapping population, QTL; (d) update the effect indicator, add or delete a main is the overall mean, l is the number of putative QTL, a q is or epistatic effect; and (e) update the number of QTL. Two the main effect of putative QTL q, b q 1 q 2 is the epistatic effect bedifferent steps were used to update the number of QTL: (1) add a QTL with main effects or epistatic effects between existtween QTL q 1 and q 2 , x iq is the indicator variable denoting the genotype of putative QTL q for individual i and is defined by ing QTL or delete an existing QTL and (2) add two new QTL 0.5 or Ϫ0.5 for the two genotypes in the mapping population, with only epistatic effect between themselves or delete two e i is the residual error assumed to follow N(0, 2 e ), ␥ q is a existing QTL. The detailed algorithms for each of these steps were described in Yi and Xu (2002) and Yi et al. (2003) . binary indicator variable for the main effect of putative QTL 20 cycles) to reduce serial correlation in the stored samples so that the total number of samples kept in the post-Bayesian analysis was 2 ϫ 10 4 . The stored samples are called posterior samples.
The posterior samples were used to obtain inferences about the parameters of interest. The posterior probability distribution of the number of QTL, p(l ϭ x|y, M) (x ϭ 0, 1, 2, . . .), was obtained by counting the number of samples in which the number of QTL is l, divided by the total of number of samples. The posterior probability that a chromosomal region contains at least one QTL was calculated as the number of samples with at least one QTL in this region over the total number of samples. QTL locations were estimated using the posterior QTL intensity function (Sillanpaa and Arjas 1998) . The posterior QTL intensity was depicted via plotting the frequency of hits by the QTL in a short interval against the genome location of the interval. The regions frequently hit by the QTL are candidate locations of the QTL. The locationwise estimates for main effect and proportion of variance explained by the main effect were obtained by calculating the mean of the estimates for these parameters in each short interval. The main effect and proportion of variance explained by the main effect at a chromosomal region were obtained similarly. Inference for the epistatic effects and the proportion of phenotypic variance explained by each epistatic effect was obtained conditional on the estimated loci falling into the corresponding chromosomal regions. The posterior probability that each epistatic effect is included in the model was calculated as the number of samples containing this epistatic effect over the total number of samples.
RESULTS

Percentage of body fat:
The posterior probability distribution of the number of QTL is given in Table 2 . Under the nonepistatic model, the variation of percentage of body fat was likely contributed by two or three loci with an equal chance ‫)%04ف(‬ in these genomic regions. However, the epistatic model analysis showed that percentage of body fat was most likely affected by included in the nonepistatic model were ‫0.1ف‬ (Table 3) , showing that these two chromosomal regions almost certainly affect percentage of body fat. In the epistatic For each trait, the phenotypic values were standardized usmodel analysis, QTL activity was detected in chromoing y i ϭ (y i Ϫ y)/s, where y is the mean and s is the standard somes 2, 7, 12, and 15. The probabilities that these deviation of y. The standardized records were subject to Bayeschromosomes included QTL were 1.00, 1.00, 0.969, and ian analysis. For all analyses, the MCMCs were started with no 0.567, respectively (Table 4) Under the nonepistatic analysis, the main effects on for updating QTL positions was chosen to be 0.5 cM. The prior chromosome 2 and 7 were estimated to account for of the QTL position was uniform over the genome region.
3.4 and 4.3% of the phenotypic variance, respectively Bayesian QTL analyses were executed with a C program (Yi (Table 3 ). The epistatic analysis estimated that these two et al. 2003) . In each analysis, the MCMC sampler was run for chromosomes explain 7.2 and 4.4% of the phenotypic 4 ϫ 10 5 cycles after discarding the first 2000 cycles for the burn-in period. The chain was thinned (one iteration saved in every variance, respectively (Table 4 ). Other chromosomes Averaged main effect for each chromosome, heritability explained by the main effect, and posterior probability that each chromosome is included in the model are shown. Posterior standard deviations of the estimates are given in parentheses. Chr, chromosome.
had weak main effects and thus were not detected in that chromosomes 2 and 7 affected adiposity index on both nonepistatic and epistatic analyses. The posterior the nonepistatic analysis. The QTL on chromosome 12, which has a weak main effect, interacts with the QTL probabilities that the loci on these two chromosomes were included were ‫0.1ف‬ in both model analyses (Taon chromosome 2 and the QTL on chromosome 15. The epistatic genetic variance was approximately equal bles 3 and 4). The posterior probabilities that chromosomes 12 and 16 include QTL were 0.509 and 0.629, to the genetic variance explained by the main effects. The posterior probabilities that these two epistatic efrespectively, under the epistatic model (Table 4) , whereas these posterior probabilities were 0.081 and 0.273 under fects are included in the model were 0.964 and 0.879, respectively. the nonepistatic model ( Table 3 ), suggesting that the loci on these two chromosomes are involved mainly in Adiposity index: There was a posterior prediction of one additional QTL when allowing for epistasis (Table 2) . epistatic interactions. As for percentage of body fat, SPRET/Ei alleles proThe profiles of QTL intensity given in Figure 3 show Averaged main effect for each chromosome, heritability explained by the main effect, and posterior probability that each chromosome is included in the model are shown. Posterior standard deviations of the estimates are given in parentheses. Chr, chromosome.
Total fat mass:
The posterior probability showed that there is most likely one QTL in these genomic regions affecting the variation of total fat mass when excluding epistasis, whereas there are three QTL when allowing for epistasis (Table 2 ). The profile of the posterior QTL intensity on chromosome 7 under the nonepistatic model is fairly similar to that under the epistatic model, indicating that the QTL on chromosome 7 affects fat mass primarily through its main effect (Figure 4) . The two models also gave similar posterior probabilities that chromosome 7 includes one QTL (Tables 3 and 4) . Chromosomes 2 and 12 have significant peaks in the epistatic plot and are essentially invisible in the nonepistatic plot (Figure 4) . Under the epistatic model, the posterior probabilities that the QTL on chromosomes 2 and 12 are included in the model were 0.956 and 0.948, respectively. Therefore, we found two additional QTL in the epistatic analysis.
As for percentage of body fat and adiposity index, SPRET/Ei alleles promote increased fat mass on chromosomes 7 and 12 and reduced fat mass on chromosome 2. The main effect on chromosome 7 in the nonepistatic and epistatic analyses was estimated to account for 2.5 and 2.1% of the phenotypic variance, respectively (Tables 3 and 4) . Under the nonepistatic model, the averaged main effects of other chromosomes were estimated to be small. As seen for percentage of body fat and adiposity, chromosome 2 strongly interacts with chromosome 12 (Table 5) : the epistatic effect between these chromosomes is Ϫ0.849, which accounts for 4.8% of the phenotypic variance, and this epistatic effect was always included in the model. Chromosome 2 also interacts with chromosome 7, but this epistatic effect explains only 1.2% of the phenotypic variance and was included in the model with probability of 0.67. the epistatic model analysis showed that body weight was most likely affected by three loci. As with the three obesity traits aforementioned, the QTL activity for body mote leanness on chromosomes 2 and 15 and obesity weight was detected in chromosome 7 in both the nonon other chromosomes (Figure 3) . The main effect on epistatic and epistatic models ( Figure 5 ) and was always chromosomes 2 and 7 explained 3.5 and 5.4% of the selected into the model (Tables 3 and 4 ). The QTL on phenotypic variance, respectively (Tables 3 and 4) . chromosomes 2 and 12 were included in the model Other chromosomes had weak main effects and thus with high probabilities of 0.873 and 0.907, respectively, were not detected in the nonepistatic analysis. Four under the epistatic model. Therefore, the QTL on chrochromosomes were involved in epistatic interactions mosomes 2 and 12 were discovered only in the epistatic (Table 5 ). The interaction of chromosome 2 with analysis. chromosome 12 was similar to that for percentage of As for the aforementioned obesity traits, SPRET/Ei body fat. The interaction between chromosomes 12 and alleles promote higher body weight on chromosomes 7 15, which was significant for percentage of body fat, did and 12, and reduced body weight on chromosome 2 not occur for adiposity index. However, two additional ( Figure 5 ). The main effect of the QTL on chromoepistatic effects, chromosome 12 with 7 and 7 with 16, some 7 was estimated to be similar under both models, were observed. Compared with those for percentage of ‫,44.0ف‬ and accounts for 4.9% of the phenotypic varibody fat, these interactions had smaller effects and each ance in the two model analyses. Under the nonepistatic model, the main effects of other chromosomes are small accounted for only ‫%7.1ف‬ of the phenotypic variance. ( Table 3 ). As with total fat mass, however, the main effects of chromosomes 2 and 12 in the epistatic analysis were much higher, Ϫ0.326 and 0.322, and account for 2.8 and 1.9% of the phenotypic variance, respectively (Table 4). As seen for the other three obesity traits, chromosome 2 strongly interacts with chromosome 12. Plasma total cholesterol: The posterior probabilities of the number of QTL show that two or three QTL in these regions were detected to influence the variation of total cholesterol ( Table 2 ). The QTL activity was found in chromosomes 6 and 12 in both the nonepistatic and epistatic model analyses (Figure 6 ). In the nonepistatic analysis, the posterior probabilities that these two chromosomes include QTL were ‫58ف‬ and 91%, respectively (Table 3 ). In the epistatic analysis, these two chromosomes were always included into the model (Table 4 ). The QTL on chromosome 7, which was found to influence all four obesity traits, was detected with small probability of 0.4 and, thus, chromosome 7 does not influence total cholesterol. These results indicate largely separate genetic control for obesity and total cholesterol.
The nonepistatic and epistatic analyses gave similar profiles of the main effect and the heritability explained by the main effect (Tables 3 and 4 ). The SPRET/Ei alleles lead to a higher value of total cholesterol. Chromosomes 6 and 12 have strong interaction, which accounted for 3.9% of the phenotypic variance (Table 5) .
Sensitivity analysis: In a Bayesian analysis, as used in this study, it is important to check for sensitivity to the choice of prior distributions. It has been shown that posterior inferences are influenced mainly by prior specifications of the number and genetic effects of QTL (Satagopan et al. 1996; Gaffney 2001; Yi et al. 2003) . Therefore, we investigated sensitivity to the choice of prior distributions for these two types of parameters. Table 6 . In this study, we adopted a Bayesian model selection In all analyses, the mode of the number of QTL was method recently developed by Yi et al. (2003) to evalestimated to be 3 or 4. Increasing the prior mean of uate potential epistatic interactions in the BSB backcross the number of QTL favored a higher number of QTL.
for four obesity traits and plasma total cholesterol. The Similarly, reducing the prior variance for genetic effects statistical approach used here models multiple QTL, also favored a higher number of QTL. Table 6 also gives their main effects, and epistatic effects simultaneously. Bayes' factor B(3, 2) for all analyses. The Bayes factor
With this statistical method, we can jointly infer the geneappeared to be less sensitive to the prior on the number tic architecture of a complex trait and estimate the associof QTL, but was greatly affected by the choice of prior ated genetic parameters, including the number, positions, variance of genetic effects. The profiles of the QTL main and epistatic effects of the identified QTL, and the intensity are depicted in Figure 7 . These profiles are genetic variance and heritability explained by each genefairly similar and thus these priors did not seem to affect tic effect. Therefore, this Bayesian mapping method can the posterior inference of QTL locations. We also found detect multiple QTL with any combination of main and that the posterior inference about the genetic effects epistatic effects. and the effect indicators were not sensitive to the priors A variety of other statistical methods for mapping epistatic QTL have been developed. The simplest method is of the number and genetic effects of QTL. to carry out two-way variance analyses for all marker not for percentage of body fat, on chromosomes 6 and 15, respectively. pairs. We used this method to test interactions between markers close to the QTL detected by the Bayesian epi-
We have now performed three additional crosses, all of which involve a strain of C57BL/6J that is constatic analysis, but found that some of the epistatic effects were not significant even under an unadjusted genic for knockout of hepatic lipase on chromosome 9 (B6-LIPC null ) and inbred SPRET/Ei (Farahani et al. threshold value, e.g ., 5% (see Table 7 ). The marker data used in this study include missing marker genotypes of 2004). BSB mice of these three crosses were maintained in a different mouse facility in different caging from 30%. The large proportion of missing values largely reduces the sample size used in variance analysis. Furthat of the previous studies, although all mice in all crosses were maintained in individual cages. As found thermore, the two-locus model approaches may ignore other potential associated QTL effects, which increases previously in the cross involving inbred SPRET/Ei (Warden et al. 1995) , in these crosses involving B6-the residual variance and thus reduces the statistical power on detecting epistasis. LIPC null and SPRET/Ei mice there is no independent QTL on chromosome 12. The chromosome 7 QTL was Using the interval-mapping method (Lander and Botstein 1989) , two previous studies searched for BSB reproduced, a new QTL was observed on chromosome 2, and there were no independent QTL on chromoobesity QTL (Warden et al. , 1995 . In those BSB crosses, the central region of chromosome 7 was signifisomes 6 and 15. The QTL on chromosome 7 was found to have significant positive main effects on the obesity cant for body weight, percentage of body fat, and body mass index as well as for plasma total cholesterol. The traits analyzed, with the SPRET/Ei allele on chromosome 7 resulting in greater obesity. In the nonepistatic central portion of chromosome 7 was discovered to be especially rich in QTL associations for obesity in several analyses, the region of chromosome 2 was found to influence only percentage of body fat and adiposity other studies as well (Warden et al. 1995; Vaughn et al. 1999; Cheverud et al. 2001) . A chromosome 12 QTL index, both of which are ratios of body fat mass to total body weight, but when allowing for epistasis, chromofor percentage of body fat was present in a BSB cross using outbred SPRET/Pt , but was somes 2 and 12 were found to influence fat mass and body weight as well. The main effects of chromosome absent in a later cross using inbred SPRET/Ei (Warden et al. 1995) , leading us to conclude that the main effect 2 for the four obesity traits were all negative, and thus the SPRET/Ei allele led to lower phenotypes of obesity of chromosome 12 QTL was weak. QTL were previously identified for femoral and mesenteric fat depots, but on chromosome 2. The previous crosses had observed 
